My Quest Story – Mark Hamilton
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Quest Diagnostics I've spent most of my career working in an...
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Quest Diagnostics I've spent most of my career working in an...
Promoting Wellness Through Community Events and Relevant AssessmentsDUBAI, UAE / ACCESSWIRE / June 12, 2024 / Physiowell Clinic, a Dubai-based...
New Formulary Strategy Advances Biosimilar Adoption and AffordabilityMILWAUKEE, WI / ACCESSWIRE / June 12, 2024 / Serve You Rx, a...
AUSTIN, TX / ACCESSWIRE / June 12, 2024 / SFWJ, doing business as Medcana, a holding company focused in the...
REDWOOD CITY, CA / ACCESSWIRE / June 12, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to...
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Gilead SciencesLuciana Preger credits being exposed to her father's work at...
CHESTNUT HILL, MA / ACCESSWIRE / June 12, 2024 / Nava Health, a leader in longevity, integrative, and functional medicine,...
Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar...
New AI-driven technology integration marks a first in the U.S., enhancing patient access to specialized care and streamlining complex scheduling...
TORONTO, ON / ACCESSWIRE / June 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s current SWEETS bispecific antibodies are...
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and...
CARSON CITY, Nev., June 12, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company...
Agreement will focus on the development of novel topical rapamycin (sirolimus) formulations as potential treatments for a number of rare...
SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025...
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on...
HOUSTON, June 12, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and...
The integration with DocuSign, a pioneer in electronic signature technology, ensures that patients can securely and conveniently obtain their medical...
CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused...